Cargando…
MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
BACKGROUND: The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional mechanisms which progress in the time leading to a severe cardiac outcome. It is also un...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753431/ https://www.ncbi.nlm.nih.gov/pubmed/36517751 http://dx.doi.org/10.1186/s10020-022-00588-0 |
_version_ | 1784850961501519872 |
---|---|
author | Totoń-Żurańska, Justyna Sulicka-Grodzicka, Joanna Seweryn, Michał T. Pitera, Ewelina Kapusta, Przemysław Konieczny, Paweł Drabik, Leszek Kołton-Wróż, Maria Chyrchel, Bernadeta Nowak, Ewelina Surdacki, Andrzej Grodzicki, Tomasz Wołkow, Paweł P. |
author_facet | Totoń-Żurańska, Justyna Sulicka-Grodzicka, Joanna Seweryn, Michał T. Pitera, Ewelina Kapusta, Przemysław Konieczny, Paweł Drabik, Leszek Kołton-Wróż, Maria Chyrchel, Bernadeta Nowak, Ewelina Surdacki, Andrzej Grodzicki, Tomasz Wołkow, Paweł P. |
author_sort | Totoń-Żurańska, Justyna |
collection | PubMed |
description | BACKGROUND: The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional mechanisms which progress in the time leading to a severe cardiac outcome. It is also unclear whether long-term transcriptomic alterations related to doxorubicin use are similar to transcriptomic patterns present in patients suffering from other cardiomyopathies. METHODS: We have sequenced miRNA from total plasma and extracellular vesicles (EVs) from 66 acute lymphoblastic leukemia (ALL) survivors and 61 healthy controls (254 samples in total). We then analyzed processes regulated by differentially expressed circulating miRNAs and cross-validated results with the data of patients with clinically manifested cardiomyopathies. RESULTS: We found that especially miRNAs contained within EVs may be informative in terms of cardiomyopathy development and may regulate pathways related to neurotrophin signaling, transforming growth factor beta (TGFβ) or epidermal growth factor receptors (ErbB). We identified vesicular miR-144-3p and miR-423-3p as the most variable between groups and significantly correlated with echocardiographic parameters and, respectively, for plasma: let-7g-5p and miR-16-2-3p. Moreover, vesicular miR-144-3p correlates with the highest number of echocardiographic parameters and is differentially expressed in the circulation of patients with dilated cardiomyopathy. We also found that distribution of particular miRNAs between of plasma and EVs (proportion between compartments) e.g., miR-184 in ALL, is altered, suggesting changes within secretory and miRNA sorting mechanisms. CONCLUSIONS: Our results show that transcriptomic changes resulting from doxorubicin induced myocardial injury are reflected in circulating miRNA levels and precede development of the late onset cardiomyopathy phenotype. Among miRNAs related to cardiac function, we found vesicular miR-144-3p and miR-423-3p, as well as let-7g-5p and miR-16-2-3p contained in the total plasma. Selection of source for such studies (plasma or EVs) is of critical importance, as distribution of some miRNA between plasma and EVs is altered in ALL survivors, in comparison to healthy people, which suggests that doxorubicin-induced changes include miRNA sorting and export to extracellular space. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-022-00588-0. |
format | Online Article Text |
id | pubmed-9753431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97534312022-12-16 MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin Totoń-Żurańska, Justyna Sulicka-Grodzicka, Joanna Seweryn, Michał T. Pitera, Ewelina Kapusta, Przemysław Konieczny, Paweł Drabik, Leszek Kołton-Wróż, Maria Chyrchel, Bernadeta Nowak, Ewelina Surdacki, Andrzej Grodzicki, Tomasz Wołkow, Paweł P. Mol Med Research Article BACKGROUND: The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional mechanisms which progress in the time leading to a severe cardiac outcome. It is also unclear whether long-term transcriptomic alterations related to doxorubicin use are similar to transcriptomic patterns present in patients suffering from other cardiomyopathies. METHODS: We have sequenced miRNA from total plasma and extracellular vesicles (EVs) from 66 acute lymphoblastic leukemia (ALL) survivors and 61 healthy controls (254 samples in total). We then analyzed processes regulated by differentially expressed circulating miRNAs and cross-validated results with the data of patients with clinically manifested cardiomyopathies. RESULTS: We found that especially miRNAs contained within EVs may be informative in terms of cardiomyopathy development and may regulate pathways related to neurotrophin signaling, transforming growth factor beta (TGFβ) or epidermal growth factor receptors (ErbB). We identified vesicular miR-144-3p and miR-423-3p as the most variable between groups and significantly correlated with echocardiographic parameters and, respectively, for plasma: let-7g-5p and miR-16-2-3p. Moreover, vesicular miR-144-3p correlates with the highest number of echocardiographic parameters and is differentially expressed in the circulation of patients with dilated cardiomyopathy. We also found that distribution of particular miRNAs between of plasma and EVs (proportion between compartments) e.g., miR-184 in ALL, is altered, suggesting changes within secretory and miRNA sorting mechanisms. CONCLUSIONS: Our results show that transcriptomic changes resulting from doxorubicin induced myocardial injury are reflected in circulating miRNA levels and precede development of the late onset cardiomyopathy phenotype. Among miRNAs related to cardiac function, we found vesicular miR-144-3p and miR-423-3p, as well as let-7g-5p and miR-16-2-3p contained in the total plasma. Selection of source for such studies (plasma or EVs) is of critical importance, as distribution of some miRNA between plasma and EVs is altered in ALL survivors, in comparison to healthy people, which suggests that doxorubicin-induced changes include miRNA sorting and export to extracellular space. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-022-00588-0. BioMed Central 2022-12-14 /pmc/articles/PMC9753431/ /pubmed/36517751 http://dx.doi.org/10.1186/s10020-022-00588-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Totoń-Żurańska, Justyna Sulicka-Grodzicka, Joanna Seweryn, Michał T. Pitera, Ewelina Kapusta, Przemysław Konieczny, Paweł Drabik, Leszek Kołton-Wróż, Maria Chyrchel, Bernadeta Nowak, Ewelina Surdacki, Andrzej Grodzicki, Tomasz Wołkow, Paweł P. MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
title | MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
title_full | MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
title_fullStr | MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
title_full_unstemmed | MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
title_short | MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
title_sort | microrna composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753431/ https://www.ncbi.nlm.nih.gov/pubmed/36517751 http://dx.doi.org/10.1186/s10020-022-00588-0 |
work_keys_str_mv | AT totonzuranskajustyna micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT sulickagrodzickajoanna micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT sewerynmichałt micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT piteraewelina micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT kapustaprzemysław micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT koniecznypaweł micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT drabikleszek micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT kołtonwrozmaria micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT chyrchelbernadeta micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT nowakewelina micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT surdackiandrzej micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT grodzickitomasz micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin AT wołkowpawełp micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin |